SNJ-1945 is a calpain inhibitor with enhanced retinal permeability, high oral bioavailability, and a long half-life; it rescues defective functions in lissencephaly, protects SH-SY5Y cells against MPP(+) and rotenone-induced toxicity, reduces retinal cell death in mice both in vitro and in vivo, and exhibits good water solubility, enabling its use as a cardioplegic agent by inhibiting α-fodrin proteolysis to prevent KCl-induced cardiac arrest and reperfusion injury associated with total Ca²⁺ overload.